Chevy Chase Trust Holdings LLC reduced its holdings in The Clorox Company (NYSE:CLX – Free Report) by 2.0% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 87,835 shares of the company’s stock after selling 1,748 shares during the quarter. Chevy Chase Trust Holdings LLC’s holdings in Clorox were worth $14,265,000 at the end of the most recent reporting period.
Other large investors also recently modified their holdings of the company. Brooklyn Investment Group increased its holdings in shares of Clorox by 163.8% in the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock worth $25,000 after acquiring an additional 95 shares in the last quarter. Prospera Private Wealth LLC bought a new stake in Clorox in the 3rd quarter valued at approximately $27,000. Continuum Advisory LLC boosted its position in Clorox by 300.0% during the 3rd quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock worth $30,000 after acquiring an additional 138 shares during the last quarter. Asset Planning Inc acquired a new position in Clorox during the 4th quarter worth approximately $32,000. Finally, Carolina Wealth Advisors LLC bought a new position in shares of Clorox during the 3rd quarter worth approximately $48,000. 78.53% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
Several research analysts recently commented on CLX shares. JPMorgan Chase & Co. increased their target price on shares of Clorox from $171.00 to $173.00 and gave the stock a “neutral” rating in a report on Tuesday, February 4th. Evercore ISI raised their price objective on Clorox from $145.00 to $155.00 in a report on Tuesday, February 4th. Wells Fargo & Company lifted their target price on Clorox from $157.00 to $161.00 and gave the company an “equal weight” rating in a research report on Tuesday, February 4th. StockNews.com cut Clorox from a “buy” rating to a “hold” rating in a research report on Sunday, January 5th. Finally, TD Cowen raised Clorox from a “sell” rating to a “hold” rating and boosted their price target for the stock from $155.00 to $170.00 in a research report on Wednesday, November 6th. Four investment analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $158.21.
Clorox Stock Down 1.9 %
Shares of CLX opened at $147.91 on Monday. The firm has a market cap of $18.31 billion, a P/E ratio of 40.41, a price-to-earnings-growth ratio of 2.52 and a beta of 0.42. The company has a debt-to-equity ratio of 20.52, a quick ratio of 0.62 and a current ratio of 0.94. The Clorox Company has a 52 week low of $127.60 and a 52 week high of $171.37. The firm’s 50-day simple moving average is $159.17 and its 200 day simple moving average is $159.42.
Clorox (NYSE:CLX – Get Free Report) last announced its earnings results on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, topping analysts’ consensus estimates of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same quarter last year, the company earned $2.16 EPS. On average, analysts forecast that The Clorox Company will post 7.15 earnings per share for the current year.
Clorox Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th were paid a dividend of $1.22 per share. The ex-dividend date was Wednesday, January 29th. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.30%. Clorox’s dividend payout ratio (DPR) is currently 133.33%.
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Featured Stories
- Five stocks we like better than Clorox
- Trading Stocks: RSI and Why it’s Useful
- Symbotic Shares Down 37%—Is It Time for Bravery or Caution?
- What Investors Need to Know About Upcoming IPOs
- High-Yield Healthcare: 3 Stocks With Strong Dividends
- Consumer Staples Stocks, Explained
- Beyond the Bargain Bin: 3 Stocks Leading Discount Retail
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.